Annovis Bio, Inc. (NYSE:ANVS) Receives Average Rating of “Buy” from Brokerages
Annovis Bio, Inc. (NYSE:ANVS – Get Free Report) has earned a consensus recommendation of “Buy” from the six analysts that are presently covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the […]
